Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2000 Jul 8;321(7253):73-7.
doi: 10.1136/bmj.321.7253.73.

Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials

Affiliations
Meta-Analysis

Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials

H C Bucher et al. BMJ. .

Abstract

Objective: To determine whether percutaneous transluminal coronary angioplasty (angioplasty) is superior to medical treatment in non-acute coronary artery disease.

Design: Meta-analysis of randomised controlled trials.

Setting: Randomised controlled trials conducted worldwide and published between 1979 and 1998.

Participants: 953 patients treated with angioplasty and 951 with medical treatment from six randomised controlled trials, three of which included patients with multivessel disease and pre-existing myocardial infarction.

Main outcome measures: Angina, fatal and non-fatal myocardial infarction, death, repeated angioplasty, and coronary artery bypass grafting.

Results: In patients treated with angioplasty compared with medical treatment the risk ratios were 0. 70 (95% confidence interval 0.50 to 0.98; heterogeneity P<0.001) for angina; 1.42 (0.90 to 2.25) for fatal and non-fatal myocardial infarction, 1.32 (0.65 to 2.70) for death, 1.59 (1.09 to 2.32) for coronary artery bypass graft, and 1.29 (0.71 to 3.36; heterogeneity P<0.001) for repeated angioplasty. Differences in the methodological quality of the trials, in follow up, or in single versus multivessel disease did not explain the variability in study results in any analysis.

Conclusions: Percutaneous transluminal coronary angioplasty may lead to a greater reduction in angina in patients with coronary heart disease than medical treatment but at the cost of more coronary artery bypass grafting. Trials have not included enough patients for informative estimates of the effect of angioplasty on myocardial infarction, death, or subsequent revascularisation, though trends so far do not favour angioplasty.

PubMed Disclaimer

Figures

Figure
Figure
Pooled risk ratios for various end points from six randomised controlled trials comparing percutaneous transluminal coronary angioplasty (PCTA) with medical treatment in patients with non-acute coronary heart disease; (CABG: coronary artery bypass grafting; n=953 for PTCA and 951 for medical treatment)

Comment in

References

    1. Gillum BS, Graves EJ, Kozak KJ National Center for Health Statistics. Trends in hospital utilization: United States, 1988-92. Washington, DC: Government Printing Office; 1996. . (DHHS publication No (PHS) 96-1785. Series 13. No 124.) - PubMed
    1. Higginson LA, Cairns JA, Smith ER. Rates of cardiac catheterization, coronary angioplasty and coronary artery bypass surgery in Canada (1991) Can J Cardiol. 1994;10:728–732. - PubMed
    1. Weaver WD, Simes RJ, Betriu A, Grines CL, Zijlstra F, Garcia E, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA. 1997;278:2093–2098. - PubMed
    1. Michels KB, Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. Circulation. 1995;91:476–485. - PubMed
    1. Bates DW, Miller E, Bernstein SJ, Hauptman PJ, Leape LL. Coronary angiography and angioplasty after acute myocardial infarction. Ann Intern Med. 1997;126:539–550. - PubMed

Publication types

MeSH terms